Companies › DCTH
DELCATH SYS INC (DCTH)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000872912 · EDGAR filings · Updated 2026-07-28
DELCATH SYS INC (DCTH) has reported institutional ownership of 47.3%, with 121 institutional managers holding positions valued at $151.5M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (1)
- 2026-07-28 — SCHEDULE 13G filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-05-14 — Insider transaction reported (Form 4)
- 2026-05-14 — Insider transaction reported (Form 4)
- 2026-05-14 — Insider transaction reported (Form 4)
- 2026-05-14 — Insider transaction reported (Form 4)
- 2026-05-14 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, DELCATH SYS INC has 121 institutional holders and institutional ownership of 47.3%.
Insider activity
Insiders reported 8 transactions (4 buys, 0 sells) across 6 reporting insiders, with a net reported value of $287.5K.
Data flags from SEC filings
Related companies
NIAGEN BIOSCIENCE INC (NAGE) · EUPRAXIA PHARMACEUTICALS INC (EPRX) · IMMUNEERING CORP (IMRX) · ORGANOGENESIS HLDGS INC (ORGO) · KORRO BIO INC (KRRO) · CVRX INC (CVRX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.